LISCure Biosciences announces research collaboration with Mayo Clinic for rare liver diseases
https://www.prnewswire.com/news-releases/liscure-biosciences-announces-research-collaboration-with-mayo-clinic-for-rare-liver-diseases-301455158.html
updates
Novartis turns to Alnylam in research deal aimed at liver failure
https://www.biopharmadive.com/news/novartis-alnylam-liver-failure-rna-research/616736/
Review in CMJ Redefines Fatty Liver Disease with Implications for Diagnosis and Treatment
The concept of metabolic (dysfunction)-associated fatty liver disease will have important implications for screening and treatment efforts https://www.prnewswire.com/news-releases/review-in-cmj-redefines-fatty-liver-disease-with-implications-for-diagnosis-and-treatment-301455573.html
Vaccines are just the beginning for RNA. The technology is being tested on heart and liver diseases.
https://www.inquirer.com/health/rna-heart-disease-cancer-vaccines-astrazeneca-20211223.html
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity
https://www.nature.com/articles/s42255-021-00501-9
Placental cell therapy could deliver new treatment options for liver disease
https://medicalxpress.com/news/2021-12-placental-cell-therapy-treatment-options.html
New PET imaging-based tool detects liver inflammation from fatty liver disease
https://health.ucdavis.edu/newsroom/news/headlines/new-pet-imaging-based-tool-detects-liver-inflammation-from-fatty-liver-disease-/2021/11
Safety and immunogenicity of SARS-CoV-2 vaccines in patients with chronic liver diseases (CHESS-NMCID 2101): A multicenter study
https://www.sciencedirect.com/science/article/pii/S154235652101346X
Eight substances added to 15th report on carcinogens
https://www.mdlinx.com/news/eight-substances-added-to-15th-report-on-carcinogens/1vGOxALVHtTFmOgCWo0ges